Identification of a vascular endothelial growth factor (VEGF) antagonist, sFlt-1, from a human hematopoietic cell line NALM-16. (Q40894974)

24 September 2017

title

Identification of a vascular endothelial growth factor (VEGF) antagonist, sFlt-1, from a human hematopoietic cell line NALM-16. (English)

1 reference

24 September 2017

0 references

0 references

Inoue T

1

1 reference

24 September 2017

Kibata K

2

1 reference

24 September 2017

Suzuki M

3

1 reference

24 September 2017

Nakamura S

4

1 reference

24 September 2017

Motoda R

5

1 reference

24 September 2017

Orita K

6

1 reference

24 September 2017

language of work or name

English

0 references

publication date

1 March 2000

1 reference

24 September 2017

1 reference

24 September 2017

volume

469

1 reference

24 September 2017

issue

1

1 reference

24 September 2017

page(s)

14-18

1 reference

Angiogenesis in cancer, vascular, rheumatoid and other disease

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2800%2901246-1

Vascular endothelial cell growth factor (VEGF) produced by A-431 human epidermoid carcinoma cells and identification of VEGF membrane binding sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2800%2901246-1

Molecular and biological properties of the vascular endothelial growth factor family of proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2800%2901246-1

High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2800%2901246-1

Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2800%2901246-1

Constitutive production and thrombin-induced release of vascular endothelial growth factor by human megakaryocytes and platelets

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2800%2901246-1

Paracrine expression of a native soluble vascular endothelial growth factor receptor inhibits tumor growth, metastasis, and mortality rate

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2800%2901246-1

Differential binding characteristics and cellular inhibition by soluble VEGF receptors 1 and 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2800%2901246-1

Establishment and characterization of human B cell precursor-leukemia cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2800%2901246-1

Production of VEGF and expression of the VEGF receptors Flt-1 and KDR in primary cultures of epithelial and stromal cells derived from breast tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2800%2901246-1

Role of vascular endothelial growth factor (VEGF) and placenta-derived growth factor (PlGF) in regulating human haemopoietic cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2800%2901246-1

Identification of a natural soluble form of the vascular endothelial growth factor receptor, FLT-1, and its heterodimerization with KDR

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2800%2901246-1

Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2800%2901246-1

10.1016/S0014-5793(00)01246-1

7 January 2021

Identifiers

DOI

1 reference

24 September 2017

1 reference